Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

848 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Hypoxia effects on oncolytic virotherapy in Cancer: Friend or Foe?
Sadri M, Najafi A, Rahimi A, Behranvand N, Hossein Kazemi M, Khorramdelazad H, Falak R. Sadri M, et al. Among authors: rahimi a. Int Immunopharmacol. 2023 Sep;122:110470. doi: 10.1016/j.intimp.2023.110470. Epub 2023 Jul 9. Int Immunopharmacol. 2023. PMID: 37433246 Review.
DNA methylation changes and inflammaging in aging-associated diseases.
Alimohammadi M, Makaremi S, Rahimi A, Asghariazar V, Taghadosi M, Safarzadeh E. Alimohammadi M, et al. Among authors: rahimi a. Epigenomics. 2022 Aug;14(16):965-986. doi: 10.2217/epi-2022-0143. Epub 2022 Aug 31. Epigenomics. 2022. PMID: 36043685 Review.
Effects of coenzyme Q10 supplementation on inflammation, angiogenesis, and oxidative stress in breast cancer patients: a systematic review and meta-analysis of randomized controlled- trials.
Alimohammadi M, Rahimi A, Faramarzi F, Golpour M, Jafari-Shakib R, Alizadeh-Navaei R, Rafiei A. Alimohammadi M, et al. Among authors: rahimi a. Inflammopharmacology. 2021 Jun;29(3):579-593. doi: 10.1007/s10787-021-00817-8. Epub 2021 May 18. Inflammopharmacology. 2021. PMID: 34008150
848 results